Meggitt PLC (MGGT) is a leading aerospace & defense business based in the UK. It opened the day at 263.1p after a previous close of 262.7p. During the day the price has varied from a low of 253.7p to a high of 264.9p. The latest price was 257.2p (25 minute delay). Meggitt is listed on the London Stock Exchange (LSE) and employs 12,599 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Meggitt's share price has had significant negative movement.
Its last market close was 292.8p, which is 52.45% down on its pre-crash value of 615.8p and 49.27% up on the lowest point reached during the March crash when the shares fell as low as 196.15p.
If you had bought £1,000 worth of Meggitt shares at the start of February 2020, those shares would have been worth £359.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £429.71.
|52-week range||196.15p - 701.8p|
|50-day moving average||278.0172p|
|200-day moving average||284.7872p|
|Wall St. target price||577.07p|
|Dividend yield||0.17p (2.21%)|
|Earnings per share (TTM)||28.3p|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2020-10-14)||-9.72%|
|1 month (2020-09-22)||1.90%|
|3 months (2020-07-21)||-17.62%|
|6 months (2020-04-21)||5.11%|
|1 year (2019-10-21)||-56.33%|
|2 years (2018-10-19)||-50.21%|
|3 years (2017-10-20)||-49.27%|
|5 years (2015-10-21)||-45.68%|
Valuing Meggitt stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Meggitt's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Meggitt's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Meggitt shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Meggitt's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0106. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Meggitt's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Meggitt's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £453.9 million.
The EBITDA is a measure of a Meggitt's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£2.1 billion|
|Operating margin TTM||15.34%|
|Gross profit TTM||£797.6 million|
|Return on assets TTM||4.35%|
|Return on equity TTM||-7.74%|
|Market capitalisation||£2.4 billion|
TTM: trailing 12 months
We're not expecting Meggitt to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Meggitt's shares have ranged in value from as little as 196.15p up to 701.8p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Meggitt's is 1.0191. This would suggest that Meggitt's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Meggitt PLC designs and manufactures components and sub-systems in the United Kingdom, rest of Europe, the United States, and internationally. The company operates through four segments: Airframe Systems, Engine Systems, Energy & Equipment, and Services & Support. It offers ice protection products, radomes, and structures; air data and flight display products; brake control and tyre pressure monitoring systems, and wheels and brakes; engine health and vibration monitors, H2/O2 analyzers, and turbine monitoring and protection products; and aircraft cameras and security systems, and wireless aircraft systems. The company also provides ammunition handling, thermal, weapon scoring, and weapon training systems; energy storage, power conversion and distribution, and power generation systems; ducting systems, engine composites, and flow control valves; and fire protection and controls comprising bleed air leak detection products, cables and clamps, electronic control units, fire and overheat detection products, and fire suppression products. In addition, it offers ground fuelling, and fuel systems and tanks; motion control actuators, electric motor drives, and electric motors; oxygen and specialty restraint safety systems; and accelerometers, ceramics, fluid sensors, magnetic and current sensors, position and inertial sensors, pressure sensors, speed sensors, and temperature sensors. Further, the company provides polymer seals; heat exchangers, printed circuit heat exchangers, thermal components, and thermal management systems; and live fire and virtual trainers, as well as aftermarket services. It serves aerospace, defense, and energy and equipment markets. The company was formerly known as Meggitt Holdings Public Limited Company and changed its name to Meggitt PLC in April 1989. Meggitt PLC was founded in 1947 and is based in Christchurch, the United Kingdom.
Everything we know about the Virpax Pharmaceuticals IPO, plus information on how to buy it.
Everything we know about the Vivos Therapeutics IPO, plus information on how to buy it.
Everything we know about the Kiromic Biopharma IPO, plus information on how to buy it.
Everything we know about the Codiak BioSciences IPO, plus information on how to buy it.
Everything we know about the Triller IPO, plus information on how to buy it.
Everything we know about the Eastern Bank IPO, plus information on how to buy it.
Everything we know about the Wish IPO, plus information on how to buy it.
Everything we know about the MINISO Group Holding Limited IPO, plus information on how to buy it.
Everything we know about the Playboy IPO, plus information on how to buy it.
Everything we know about the iHuman IPO, plus information on how to buy it.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.